Celularity Inc (CELU)

NASDAQ
3.22
-0.03(-0.86%)
  • Volume:
    224,179
  • Day's Range:
    3.14 - 3.34
  • 52 wk Range:
    2.72 - 13.19

CELU Overview

Prev. Close
3.25
Day's Range
3.14-3.34
Revenue
25.19M
Open
3.25
52 wk Range
2.72-13.19
EPS
0.251
Volume
224,179
Market Cap
462.88M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
624,878
P/E Ratio
-
Beta
-
1-Year Change
-59.27%
Shares Outstanding
142,424,187
Next Earnings Date
Nov 11, 2022
What is your sentiment on Celularity?
or
Vote to see community's results!

Celularity Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Celularity Inc Company Profile

Celularity Inc Company Profile

Employees
225

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company’s lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-001, placental-derived unmodified natural killer (NK) cell that is in Phase I clinical trial to treat acute myeloid leukemia, as well as in Phase I/IIa clinical trial for the treatment of glioblastoma multiforme and COVID-19; CYNK-101, an allogeneic genetically modified NK cell, which is in Phase I clinical trial to treat HER2+ gastric and gastroesophageal cancers; APPL-001, a placenta-derived mesenchymal-like adherent stromal cell that is in a pre-clinical stage for the treatment of Crohn’s disease; and PDA-002, a placenta-derived mesenchymal-like adherent stromal cell, which is in pre-clinical stage for the treatment of facioscapulohumeral muscular dystrophy. It also sells and licenses products that are used in surgical and wound care markets, such as Biovance and Interfyl; collects stem cells from umbilical cords and placentas; and provides cells storage under the LifebankUSA brand. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellBuyBuySellStrong Sell
Technical IndicatorsStrong SellStrong BuyStrong BuySellStrong Sell
SummaryStrong SellStrong BuyStrong BuySellStrong Sell
  • good opportunity to get in?
    0
    • 🤠
      0